Inflammatory responses in esophageal mucosa before and after laparoscopic antireflux surgery

Figure 2 Significant gene expression. A: Significant gene expression in the post-laparoscopic anti-reflux surgery group compared to healthy controls; B: Significant gene expression in the post-laparoscopic anti-reflux surgery group compared to pre-laparoscopic anti-reflux surgery group. All comparisons are given as fold changes. BCL3: B-cell CLL/lymphoma 3; FGF2: Fibroblast growth factor 2; IFNAR1: Interferon (alpha, beta and omega) receptor 1; IKBKE: Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon; JUN: Jun proto-oncogene; MAP2K4: Mitogen-activated protein kinase 4; EGF: Epidermal growth factor; TNFRSF1A: Tumor necrosis factor receptor superfamily, member 1A.